Journal Management System
 
Home  |   Add your Journal  |   eJManager Features  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
Periodical of Yerküre
Journal Home Page
ISSN: 1017-7833 (Print)
ISSN: 1302-9657 (Online)
Language: [ English ]  

  » Volume 26, Issue 2
      pp. 93-206
  » Volume 26, Issue 1
      pp. 1-90

 KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. Year: 2016, Volume: 26, Issue: 2

    Editorial

  1. Psychobiotics: the potential therapeutic promise of microbes in psychiatry
    Gokben Hizli Sayar, Mesut Cetin
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 93-102
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20160531111208

  2. Original Research

  3. Pharmacological modulation of Heat Shock Protein 70 (HSP70) - dependent mechanisms of endogenous neuroprotection in conditions of prenatal chronic alcoholism by Cerebrocurin and Tiocetam
    Igor F. Belenichev, Elena P. Sokolik, Nina V. Bukhtiarova, Sergii V. Levich
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 103-8
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151003061901

  4. The changes of the cognitive and psychomotor functions in the chronic cannabis users after a month of remission
    Gokhan Umut, Murat Ilhan Atagun, Cuneyt Evren, Hanife Yilmaz Cengel, Ozge Hisim, Cahit Keskinkilic
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 109-18
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151019014343

  5. Antioxidant status and DNA damage in children with attention deficit hyperactivity disorder with or without comorbid disruptive behavioral disorders
    Seref Simsek, Salih Gencoglan, Soner Ozaner, Ibrahim Kaplan, Mehmet Cemal Kaya
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 119-25
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151003063820

  6. Effects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting
    Esra Cop, Ozgur Oner, Pinar Yurtbasi, Kerim Munir
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 126-33
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20150703013708

  7. Association of 5-HT1A and 5-HT1B gene polymorphisms with obsessive-compulsive disorder in a Turkish population
    Secil Aldemir, Muradiye Acar, Zeynep Ocak, Ercan Dalbudak, Muhammet Ramazan Yigitoglu, Esra Gunduz
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 134-40
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151003063454

  8. The effects of Buprenorphine/Naloxane maintenance treatment on the quality of life, substance use and functionality in opiate dependence: a follow-up study
    Selahattin Bolek, Ilhan Yargic, Okan Ekinci
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 141-51
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151101022909

  9. Determination of CYP2C19 polymorphism, side effects, and medication adherence in patients who have utilized selective serotonin reuptake inhibitors
    Semanur Deniz, Mesut Sancar, Betul Okuyan, Pinar Ata, Ozlem Bingol Ozakpinar, Anil Talas, Tufan Gunes, Mecit Caliskan, Fikret Vehbi Izzettin
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 152-60
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151003060610

  10. Prevalence of restless legs syndrome among psychiatric patients who are under antidepressant or antipsychotic monotherapy
    Murat Semiz, Volkan Solmaz, Durdane Aksoy, Sema Inanir, Burcin Colak, Mehmet Aziz Gokbakan, Ahmet Inanir
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 161-8
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20150908024954

  11. The frequency of benzodiazepine use in the Isparta Province
    Abdullah Akpinar, Ayse Rumeysa Yaman, Kadir Karakus, Inci Meltem Atay, Kadir Demirci
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 169-74
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20150707103818

  12. Validity and reliability of “AM SAD”, a short geriatric depression screening tool, in Turkish elderly people
    Pinar Soysal, Ahmet Turan Isik, Cansu Usarel, Derya Kaya, Hulya Ellidokuz, George T. Grossberg
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 175-80
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20150910032337

  13. Case Report

  14. Aripiprazole can a viable choice for persistant suppression of symptoms in managing chronic tic disorders and Tourette’s disorder through the life span: a case series
    Sarper Taskiran, Ali Evren Tufan, Bengi Semerci
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 181-5
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20160220032354

  15. Sudden death associated with hypersensitivity myocarditis induced by clozapine: An autopsy case
    Huseyin Es, Ipek Esen Melez, Ayse Ozgun, Deniz Oguzhan Melez, Cisem Kertmen, Mehmet Cavlak
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 186-90
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151216022322

  16. Missing the diagnosis in a young woman with repeated hospital admissions: a case report
    Zhe Li, Zhenzhen Xiong, Xiehe Liu, Xiangdong Tang, Tao Li
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 191-5
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20160105112215

  17. Review Article

  18. The neuroinflammation perspective of depression: reuniting the outstanding mechanisms of the pathophysiology
    Ceren Sahin, Serdar Dursun, Mesut Cetin, Feyza Aricioglu
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 196-206
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20160520092044

  19. Letter to the Editor

  20. Propolis as a complex compound may contain many active ingredients like caffeic acid phenethyl ester (CAPE)
    Mehmet Akif Gulec, Omer Akyol, Sumeyya Akyol
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 207-8
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151006014845

  21. Massive creatine kinase elevation during antipsychotic drug treatment with olanzapine and quetiapine
    Huriye Ersen, Fulya Maner
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 208-9
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151219072041

  22. Hyperprolactinemia is a major problem in patients treated with antipsychotic drugs
    Kamil Baskoy, Seyid Ahmet Ay, Ferhat Deniz, Arif Yonem
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 210-1
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151209125410

  23. Faces and shadows: cabergoline-induced acute psychosis in a woman with no previous psychiatric history
    Zeynep Ozturk
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 211-2
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151203010237

  24. Priapism associated with aripiprazole and quetiapine in an 8-year-old boy with autism
    Asli Surer Adanir
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 212-3
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20151221101229

  25. Sertraline-induced diplopia
    Safak Eray, Halit Necmi Ucar, Ayse Pinar Vural
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY. 2016; 26(2): 213-4
    » Abstract » PDF Fulltext» doi: 10.5455/bcp.20160109124021





 




» For Authors




Become Reviewer


» Login Area






Follow ScopeMed on Twitter

ScopeMed Home
Job Opportunities/Service Offers
About ScopeMed
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of SAGEYA Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.